Effects of reciprocal chimeras between the C-terminal portion of third intracellular loops of the human dopamine D2 and D3 receptors

FEBS Letters

Volumn 447, Issue 2-3, 1999, Pages 251-256

  Filteau, Frédéric ^a,b   Veilleux, François ^a   Lévesque, Daniel ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Chimera; Cyclic AMP; Dopamine receptor D2; Dopamine receptor D3; G protein coupled receptor; GTP shift

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; ADENYLATE CYCLASE; APOMORPHINE; CLOZAPINE; CYCLIC AMP; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL; ISOBUTYLMETHYLXANTHINE; PERGOLIDE; QUINPIROLE; RACLOPRIDE; RECEPTOR SUBTYPE; RISPERIDONE; UNCOUPLING PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CHIMERA; CHO CELL; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; SECOND MESSENGER; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHO CELLS; CRICETINAE; CYCLIC AMP; DNA PRIMERS; GTP-BINDING PROTEINS; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0032970513     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)00290-2     Document Type: Article

References (38)

1. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Physiol. Rev. 78:1998;189-225.
2. Sokoloff P., Giros B., Martres M.-P., Bouthenet M.-L., Schwartz J.-C. Nature. 347:1990;146-151.
3. Cox B.A., Rosser M.P., Kozlowski M.R., Duwe K.M., Neve R.L., Neve K.A. Synapse. 21:1995;1-9.
4. MacKenzie R.G., Van Leeuwen D., Pugsley T.A., Shih Y.-H., Demattos S., Tang L., Todd R.D., O'Malley K.L. Eur. J. Pharmacol. 266:1994;79-85.
5. Pilon C., Lévesque D., Dimitriadou V., Griffon N., Martres M.-P., Schwartz J.-C., Sokoloff P. Eur. J. Pharmacol. 268:1994;129-139.
6. Seabrook G.R., Kemp J.A., Freedman S.B., Patel S., Sinclair H.A., McAllister G. Br. J. Pharmacol. 111:1994;391-393.
7. Seabrook G.R., Patel S., Marwood R., Emms F., Knowles M.R., Freedman S.B., McAllister G. FEBS Lett. 312:1992;123-126.
8. Sokoloff P., Andrieux M., Besançon R., Pilon C., Martres M.-P., Giros B., Schwartz J.-C. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 225:1992;331-337.
9. Freedman S.B., Patel S., Marwood R., Emms F., Seabrook G.R., Knowles M.R., McAllister G. J. Pharmacol. Exp. Ther. 268:1994;417-426.
10. Chio C.L., Lajiness M.E., Huff R.M. Mol. Pharmacol. 45:1994;51-60.
11. Potenza M.N., Graminski G.F., Schmauss C., Lerner M.R. J. Neurosci. 14:1994;1463-1476.
12. Griffon N., Pilon C., Sautel F., Schwartz J.-C., Sokoloff P. J. Neurochem. 68:1997;1-9.
13. Liu L.X., Monsma J.F.J., Sibley D.R., Chiodo L.A. Synapse. 24:1996;156-164.
14. Werner P., Hussy N., Buell G., Jones K.A., North R.A. Mol. Pharmacol. 49:1996;656-661.
15. Pugsley T.A., Davis M.D., Akunne H.C., MacKenzie R.G., Shih Y.-H., Damsma G., Wikström H., Whetzel S.Z., Georgic L.M., Cooke L.W., Demattos S.B., Corbin A.E., Glase S.A., Wise L.D., Dijkstra D., Heffner T.G. J. Pharmacol. Exp. Ther. 275:1995;1355-1366.
16. Castro S.W., Strange P.G. FEBS Lett. 315:1993;223-226.
17. Lévesque D., Diaz J., Pilon C., Martres M.-P., Giros B., Souil E., Schott D., Morgat J.-L., Schwartz J.-C., Sokoloff P. Proc. Natl. Acad. Sci. USA. 89:1992;8155-8159.
18. Robinson S.W., Caron M.G. Mol. Pharmacol. 52:1997;508-514.
19. Watts V.J., Neve K.A. Mol. Pharmacol. 52:1997;181-186.
20. McAllister G., Knowles M.R., Patel S., Marwood R., Emms F., Seabrook G.R., Graziano M., Borkowski D., Hey P.J., Freedman S.B. FEBS Lett. 324:1993;81-86.
21. Robinson S.W., Jarvie K.R., Caron M.G. Mol. Pharmacol. 46:1994;352-356.
22. Robinson S.W., Caron M.G. J. Neurochem. 67:1996;212-219.
23. Van Leeuwen D.H., Eisenstein J., O'Malley K., MacKenzie R.G. Mol. Pharmacol. 48:1995;344-351.
24. Grandy D.K., Marchionni M.A., Makam H., Stofko R.E., Alfano M., Frothingham L., Fischer J.B., Burke-Howie K.J., Bunzow J.R., Server A.C., Civelli O. Proc. Natl. Acad. Sci. USA. 86:1989;9762-9766.
25. Giros B., Martres M.-P., Sokoloff P., Schwartz J.-C. CR Acad. Sci. Paris III. 311:1990;501-508.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. Biol. Chem. 193:1951;265-275.
27. Wade S.M., Scribner M.K., Dalman H.M., Taylor J.M., Neubig R.R. Mol. Pharmacol. 50:1996;351-358.
28. Kjelsberg M.A., Cotecchia S., Ostrowski J., Caron M.G., Lefkowitz R.J. J. Biol. Chem. 267:1992;1430-1433.
29. Griffon N., Pilon C., Sautel F., Schwartz J.-C., Sokoloff P. J. Neural Transm. 103:1996;1163-1175.
30. Malmberg A., Mikaels A., Mohell N. J. Pharmacol. Exp. Ther. 285:1998;119-126.
31. Liggett S.B., Caron M.G., Lefkowitz R.J., Hnatowich M. J. Biol. Chem. 266:1991;4816-4821.
32. Varrault A., Le Nguyen D., McClue S., Harris B., Jouin P., Bockaert J. J. Biol. Chem. 269:1994;16720-16725.
33. Burstein E.S., Spalding T.A., Hill-Eubanks D., Brann M.R. J. Biol. Chem. 270:1995;3141-3146.
34. Eason M.G., Liggett S.B. J. Biol. Chem. 271:1996;12826-12832.
35. Wonerow P., Schöneberg T., Schultz G., Gudermann T., Paschke R. J. Biol. Chem. 273:1998;7900-7905.
36. Neubig R.R. Semin. Neurosci. 9:1998;189-197.
37. Malek D., Munch G., Palm D. FEBS Lett. 325:1993;215-219.
38. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099-3108.